Bacillus subtilis: a potential growth promoter in weaned pigs in comparison to carbadox.
Animals
Anti-Bacterial Agents
/ pharmacology
Bacillus subtilis
/ physiology
Carbadox
/ pharmacology
Diarrhea
/ drug therapy
Diet
/ veterinary
Enterotoxigenic Escherichia coli
/ physiology
Escherichia coli Infections
/ drug therapy
Feces
/ microbiology
Female
Ileum
/ drug effects
Intestinal Mucosa
/ drug effects
Male
Probiotics
/ pharmacology
Random Allocation
Swine
Swine Diseases
/ drug therapy
Weaning
Bacillus subtilis
Escherichia coli
diarrhea
gut health
immunity
weaned pigs
Journal
Journal of animal science
ISSN: 1525-3163
Titre abrégé: J Anim Sci
Pays: United States
ID NLM: 8003002
Informations de publication
Date de publication:
01 Sep 2020
01 Sep 2020
Historique:
received:
24
07
2020
accepted:
27
08
2020
pubmed:
3
9
2020
medline:
28
11
2020
entrez:
3
9
2020
Statut:
ppublish
Résumé
The study was conducted to investigate the efficacy of a probiotic Bacillus subtilis strain on growth performance, diarrhea, systemic immunity, and intestinal health of weaned pigs experimentally infected with an enterotoxigenic Escherichia coli and to compare the efficacy of B. subtilis with that of carbadox. Weaned pigs (n = 48, 6.17 ± 0.36 kg body weight [BW]) were individually housed in disease containment rooms and randomly allotted to one of four dietary treatments: negative control (NC, control diet without E. coli challenge), positive control (PC, control diet with E. coli challenge), and supplementation of 50 mg/kg of carbadox (antibiotic growth promotor [AGP]) or 2.56 × 109 CFU/kg of B. subtilis probiotics (PRO). The experiment lasted for 28 d with 7 d before and 21 d after the first E. coli inoculation. Fecal and blood samples were collected on days 0, 3, 7, 14, and 21 post inoculation (PI) to analyze β-hemolytic coliforms and complete blood cell count, respectively. Diarrhea score was recorded daily for each pig to calculate the frequency of diarrhea. All pigs were euthanized at day 21 PI to collect jejunal and ileal mucosa for gene expression analysis. Pigs in AGP had greater (P < 0.05) BW on days 7, 14, and 21 PI than pigs in PC and PRO groups. Supplementation of PRO enhanced pigs' BW on day 21 PI compared with the PC. Escherichia coli F18 challenge reduced (P < 0.05) average daily gain (ADG) and feed efficiency from day 0 to 21 PI, while supplementation of carbadox or PRO enhanced ADG and feed efficiency in E. coli F18-challenged pigs from day 0 to 21 PI. Pigs in AGP and PRO groups had reduced (P < 0.05) frequency of diarrhea throughout the experiment and fecal β-hemolytic coliforms on day 7 PI than pigs in the PC. Pigs in PRO had greater (P < 0.05) gene expression of CLDN1 in jejunal mucosa than pigs in the PC. Supplementation of carbadox or PRO reduced (P < 0.05) the gene expression of IL6 and PTGS2 in ileal mucosa of E. coli-infected pigs compared with pigs in the PC. Pigs in the PRO group had lower (P < 0.05) white blood cell number and neutrophil count, and serum haptoglobin concentration on day 7 PI, and less (P < 0.05) monocyte count on day 14 PI, compared with PC. In conclusion, supplementation of probiotic B. subtilis could enhance disease resistance and promote the growth performance of weaned pigs under disease challenge conditions. The potential mechanisms include but not limited to enhanced gut barrier integrity and local and systemic immune responses of weaned pigs.
Identifiants
pubmed: 32877510
pii: 5900678
doi: 10.1093/jas/skaa290
pmc: PMC7523599
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Carbadox
M2X04R2E2Y
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of the American Society of Animal Science. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Poult Sci. 2007 Apr;86(4):605-9
pubmed: 17369528
J Anim Sci. 2012 Nov;90(11):3709-17
pubmed: 22859771
Mol Microbiol. 2005 May;56(4):845-57
pubmed: 15853875
Poult Sci. 1991 Aug;70(8):1781-9
pubmed: 1717968
Asian-Australas J Anim Sci. 2014 Aug;27(8):1131-40
pubmed: 25083107
Vet Microbiol. 2004 Oct 5;103(1-2):29-33
pubmed: 15381263
Animal. 2011 Mar;5(3):462-70
pubmed: 22445413
Front Microbiol. 2017 Aug 10;8:1490
pubmed: 28848511
Ann N Y Acad Sci. 2017 Jun;1397(1):66-79
pubmed: 28493289
J Anim Sci. 2013 Nov;91(11):5294-306
pubmed: 24045466
J Nutr. 2007 Dec;137(12):2709-16
pubmed: 18029488
J Anim Sci. 1997 May;75(5):1244-55
pubmed: 9159271
Am J Pathol. 2005 Feb;166(2):409-19
pubmed: 15681825
Porcine Health Manag. 2016 Sep 1;2:20
pubmed: 28405446
Anim Biotechnol. 2006;17(2):217-31
pubmed: 17127532
Anim Nutr. 2018 Jun;4(2):151-159
pubmed: 30140754
Anim Biotechnol. 2006;17(2):207-15
pubmed: 17127531
FEMS Microbiol Lett. 2008 Jan;278(2):137-45
pubmed: 17995951
J Vet Sci. 2019 Jan 31;20(1):43-50
pubmed: 30481984
Am J Clin Nutr. 2001 Jun;73(6):1131S-1141S
pubmed: 11393191
J Anim Sci Biotechnol. 2019 Sep 12;10:74
pubmed: 31528339
J Anim Sci. 1993 Aug;71(8):2140-6
pubmed: 8376238
Vet Microbiol. 2013 May 3;163(3-4):392-4
pubmed: 23395292
J Biol Chem. 2011 Sep 9;286(36):31263-71
pubmed: 21771795
Clin Exp Allergy. 2005 Dec;35(12):1557-64
pubmed: 16393321
Can J Vet Res. 2002 Apr;66(2):73-8
pubmed: 11989737
J Anim Sci. 2012 Jan;90(1):345-60
pubmed: 21908641
J Anim Sci. 1982 Nov;55(5):1109-17
pubmed: 7174553
J Anim Sci. 2014 Oct;92(10):4557-65
pubmed: 25267997
J Anim Sci. 2000 Jul;78(7):1885-91
pubmed: 10907831
Anim Health Res Rev. 2005 Jun;6(1):17-39
pubmed: 16164007
J Immunol. 2008 Apr 15;180(8):5653-61
pubmed: 18390750
PLoS One. 2015 Aug 21;10(8):e0136450
pubmed: 26296207
Cold Spring Harb Perspect Biol. 2018 Jan 2;10(1):
pubmed: 28507021
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Proc Natl Acad Sci U S A. 2015 May 5;112(18):5649-54
pubmed: 25792457
Anim Health Res Rev. 2001 Dec;2(2):129-40
pubmed: 11831435
Front Microbiol. 2014 Jun 10;5:276
pubmed: 24959163
J Immunol. 2011 Nov 15;187(10):5255-67
pubmed: 21967897
Antimicrob Agents Chemother. 1978 May;13(5):770-83
pubmed: 352264
Annu Rev Microbiol. 2014;68:297-315
pubmed: 25002091
J Anim Sci. 2008 Apr;86(4):836-47
pubmed: 18192551
Infect Immun. 2013 Aug;81(8):2819-27
pubmed: 23716609
Physiol Rev. 2013 Oct;93(4):1721-41
pubmed: 24137020
Can J Vet Res. 2003 Oct;67(4):283-90
pubmed: 14620865
J Anim Sci Biotechnol. 2014 Jan 10;5(1):5
pubmed: 24410946
Vet Pathol. 1987 Jan;24(1):71-9
pubmed: 3548024